Ventas Issues Investor Presentation for Upcoming Investor Conferences

CHICAGO--(BUSINESS WIRE)-- Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that it has issued an investor presentation for upcoming investor conferences, which is available on the Company’s website at ir.ventasreit.com/events-and-presentations for a limited period following the conferences.

Company management will make a presentation at the Citi 2026 Global Property CEO Conference on March 3, 2026, at 2:55 p.m. Eastern Time.

Additionally, management will make a presentation at the Raymond James 2026 Institutional Investors Conference on March 4, 2026, at 10:25 a.m. Eastern Time.

The live webcasts of both presentations will be accessible on the Company’s website at ir.ventasreit.com/events-and-presentations. The replays of the webcasts will be archived at ir.ventasreit.com/events-and-presentations for a limited period following the events.

About Ventas

Ventas, Inc. (NYSE: VTR) is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company’s growth is fueled by its over 850 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OI™ platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas’s seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260302380292/en/

Ventas, Inc.
BJ Grant
(877) 4-VENTAS

Source: Ventas, Inc.

You May Also Be Interested In

• FairJourney Bio Delivers Antibody Engineering for Novel Tumor-Conditional IL-12 Therapeutic Approach That Unlocks the Potential of Localized Cytokine Activation
• Mitsubishi Electric Agrees to Wholly Acquire PCI Energy Solutions
• ICG: Oxy Capital Comments on the Half-Year Results of Irish Continental Group PLC (“ICG”) and the Independent Board’s Response to Its Letter